Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Large 60S subunit nuclear export GTPase 1 (LSG1) is an essential GTPase enzyme involved in the biogenesis and nuclear export of the 60S ribosomal subunit in eukaryotic cells[1][2]. LSG1 plays a crucial role in releasing NMD3 from the 60S ribosomal subunit after export from the nucleus to the cytoplasm, a step required for the proper assembly of functional ribosomes[2]. The protein is predominantly localized to the endoplasmic reticulum and, in some cases, found in discrete nuclear structures such as Cajal bodies[1]. LSG1 is part of the evolutionarily conserved YRG (YlqF Related GTPases) family, and its GTPase activity is essential for cell viability, nucleocytoplasmic transport, and rRNA maturation[1][3]. Direct drug targeting of LSG1 has not been reported, and it is not currently considered a therapeutic target in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large 60S subunit nuclear export GTPase 1 (LSG1).